World's Best Scientists 2026 revealed!

David Bowen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David Bowen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

The last bar groups every scientist with 807 publications or more.

David Bowen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David Bowen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

The last bar groups every scientist with 157 D-Index or more.

Overview

David Bowen is affiliated with the Royal Prince Alfred Hospital in Australia and has a substantial body of research primarily in the fields of Medicine and Immunology and Microbiology. Their work includes a focus on Immunology, Surgery, Epidemiology, Hepatology, and Pharmacology.

Bowen's research topics cover a range of areas particularly centered on immune system functions and responses, including:

  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Organ Transplantation Techniques and Outcomes
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Renal Transplantation Outcomes and Treatments

The scientist has published multiple papers across various well-recognized venues. Frequent publication venues include:

  • Pathology
  • Transplantation
  • BMC Medical Education
  • Journal of Clinical Investigation
  • Immunology and Cell Biology

Selected recent publications are:

  • "Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients," 2023, New England Journal of Medicine
  • "A Natural Peptide Antigen within the Plasmodium Ribosomal Protein RPL6 Confers Liver TRM Cell-Mediated Immunity against Malaria in Mice," 2020, Cell Host & Microbe
  • "Glycolipid-peptide vaccination induces liver-resident memory CD8 + T cells that protect against rodent malaria," 2020, Science Immunology
  • "Research supervisors' views of barriers and enablers for research projects undertaken by medical students; a mixed methods evaluation of a post-graduate medical degree research project program," 2022, BMC Medical Education
  • "The self-peptide repertoire plays a critical role in transplant tolerance induction," 2021, Journal of Clinical Investigation

David Bowen frequently collaborates with several researchers, including:

  • Patrick Bertolino
  • Geoffrey W. McCaughan
  • Simone I. Strasser
  • Ken Liu
  • Catriona McKenzie

Best Publications

  • Adaptive immune responses in acute and chronic hepatitis C virus infection

    David G. Bowen;Christopher M. Walker

  • Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

    Nicolas Goardon;Emanuele Marchi;Ann Atzberger;Lynn Quek

  • Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    Luca Malcovati;Eva Hellström-Lindberg;David Bowen;Lionel Adès

  • Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

    P Fenaux;MC Le Deley;S Castaigne;E Archimbaud

  • Liver-Resident Memory CD8 + T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection.

    Daniel Fernandez-Ruiz;Wei Yi Ng;Wei Yi Ng;Lauren E Holz;Joel Z Ma

  • Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

    Petter S. Woll;Una Kjällquist;Onima Chowdhury;Helen Doolittle

  • Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

    Theo De Witte;David Bowen;Marie Robin;Luca Malcovati

  • The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity

    David G. Bowen;Monica Zen;Lauren Holz;Thomas Davis

  • Results of the phase i trial of RG7112, a small-molecule MDM2 antagonist in leukemia

    Michael Andreeff;Kevin R. Kelly;Karen Yee;Sarit Assouline

  • Mutational escape from CD8+ T cell immunity HCV evolution, from chimpanzees to man

    David G. Bowen;Christopher M. Walker

  • T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells

    Alessandra Warren;David G. Le Couteur;Robin Fraser;David G. Bowen

  • Antigen-specific primary activation of CD8+ T cells within the liver.

    Patrick Bertolino;David G. Bowen;Geoffrey W. McCaughan;Barbara Fazekas de St. Groth

  • A Liver Capsular Network of Monocyte-Derived Macrophages Restricts Hepatic Dissemination of Intraperitoneal Bacteria by Neutrophil Recruitment

    Frederic Sierro;Maximilien Evrard;Simone Rizzetto;Michelle Melino

  • Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia

    Hagop M Kantarjian;Pierre Fenaux;Mikkael A. Sekeres;Pamela S. Becker

  • Role of primary intrahepatic T-cell activation in the 'liver tolerance effect'.

    Patrick Bertolino;Geoffrey W McCaughan;David G Bowen

  • Hepatocyte entry leads to degradation of autoreactive CD8 T cells

    Volker Benseler;Alessandra Warren;Michelle Vo;Lauren E. Holz

  • The liver: a special case in transplantation tolerance.

    Volker Benseler;Geoffrey W. McCaughan;Hans J. Schlitt;G. Alex Bishop

  • Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome

    Alexander Sternberg;Sally Killick;Tim Littlewood;Chris Hatton

  • No increase in age-specific incidence of myelodysplastic syndromes

    Ulrich Germing;Corinna Strupp;Andrea Kündgen;David Bowen

  • p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

    Leonie Saft;Mohsen Karimi;Mehran Ghaderi;András Matolcsy

Frequent Co-Authors

Patrick Bertolino
Patrick Bertolino Centenary Institute of Cancer Medicine and Cell Biology
Ian E. Alexander
Ian E. Alexander University of Sydney
William R. Heath
William R. Heath University of Melbourne
Peter J. Campbell
Peter J. Campbell Wellcome Sanger Institute
Christopher M. Walker
Christopher M. Walker The Ohio State University
Irina Caminschi
Irina Caminschi Monash University
Geoffrey I. McFadden
Geoffrey I. McFadden University of Melbourne
Andrea Pellagatti
Andrea Pellagatti University of Oxford
Wolfgang Weninger
Wolfgang Weninger Medical University of Vienna
Scott N. Mueller
Scott N. Mueller University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your knowledge through related online degrees can open doors to rewarding healthcare careers. Many students consider nursing as a complementary field, and options like 12-month accelerated nursing programs online for non nurses offer a fast track to gain essential clinical skills without prior nursing experience.

If you're looking for a more straightforward entry, exploring accelerated nursing programs provides a quicker route to obtaining a Bachelor of Science in Nursing, ideal for those eager to start practicing sooner.

Licensed Practical Nurse (LPN) roles are another viable path, especially through accredited LPN programs easy to get into, which offer accessible entry points into nursing careers with practical, hands-on training.

For advanced practice, pursuing a Nurse Practitioner (NP) degree is a logical step, with many students opting for the what is the easiest np program to balance rigorous education and timely completion. These pathways integrate well with Immunology expertise, enabling a broad scope of patient care and research opportunities.

Best Scientists Citing David Bowen

Trending Scientists

Recently Published Articles